Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03655002
Title IRX-2, Cyclophosphamide, and Nivolumab in Treating Participants With Recurrent or Metastatic and Refractory Liver Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors City of Hope Medical Center

hepatocellular carcinoma


Cyclophosphamide + IRX-2 + Nivolumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
City of Hope Medical Center Duarte California 91010 United States Details
Texas Oncology at Baylor Charles A Sammons Cancer Center Dallas Texas 75246 United States Details
*Shaded cells indicate that there was no data available from for the field